We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
To own Parsons today, you need to believe in its ability to convert a growing backlog of complex U.S. defense and infrastructure work into more stable, higher quality earnings while managing contract and acquisition risk. The August contract wins deepen its exposure to mission-critical, long-duration programs, which may support visibility around the near term catalyst of earnings consistency. At the same time, they do little to reduce the core risk of dependence on large U.S. government awards and budget decisions.
The US$514 million option on the Missile Defense Agency TEAMS Next contract is the clearest link to this story. It extends an existing, technically demanding program where Parsons already has a track record, and it fits squarely within the consensus catalyst of shifting toward higher value, tech-heavy federal work. For investors focused on the tension between contract volatility and earnings quality, this award is a useful case study in how Parsons’ mix might evolve.
Yet, against these contract wins, investors should still be aware of how exposed Parsons remains to large, lumpy federal programs and shifting procurement priorities...
Read the full narrative on Parsons (it's free!)
Parsons' narrative projects $7.2 billion revenue and $407.1 million earnings by 2029. This requires 4.7% yearly revenue growth and about a $249.7 million earnings increase from $157.4 million today.
Uncover how Parsons' forecasts yield a $58.55 fair value, a 19% upside to its current price.
Some of the lowest ranked analysts were already cautious, assuming revenue of about US$7.4 billion and earnings near US$348 million by 2029, and this new wave of missile defense and space awards could either soften or reinforce their more pessimistic view about Parsons’ dependence on big government contracts.
Explore 4 other fair value estimates on Parsons - why the stock might be worth just $58.55!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com